Rgenta Therapeutics Enters Strategic Collaboration with GSK for RNA-Targeted Therapies#United_States#GSK#Rgenta_Therapeutics#RNA-Targeted_Therapies#Woburn
Rgenta Therapeutics Enters Strategic Collaboration with GSK for RNA-Targeted Therapies
Rgenta Therapeutics and GSK form a strategic alliance to develop novel RNA-targeted small molecule splice modulators for various diseases.
third-news.com
December 4, 2024 at 1:25 PM
Rgenta Therapeutics Enters Strategic Collaboration with GSK for RNA-Targeted Therapies#United_States#GSK#Rgenta_Therapeutics#RNA-Targeted_Therapies#Woburn